Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-016991
Filing Date
2016-06-07
Accepted
2016-06-07 16:43:03
Documents
1
Period of Report
2016-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146533216978746.html 4  
1 FORM 4 wf-form4_146533216978746.xml 4 3866
  Complete submission text file 0001628280-16-016991.txt   5328
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Higgins Michael J (Reporting) CIK: 0001478521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 161701736